Express News | Biophytis Announces The Design Of Its Phase 2 OBA Clinical Study In Obesity With BIO101 (20-hydroxyecdysone)
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Caterpillar Inc. (NYSE:CAT) fell sharply during Thursday's session after the company reported better-than-expected first-quarter EPS but missed revenue estimates.Caterpillar reported a first
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading
European equities traded in the US as American depositary receipts were trending modestly higher Thursday morning, rising 0.24% to 1,364.10 on the S&P Europe Select ADR Index. From continental Europe,
Optinose OPTN Product Revenue; Biophytis BPTS NASDAQ Delist
Top Premarket Decliners
Biophytis (BPTS) shares slumped 15% Thursday premarket after the company said it will transfer its American Depositary Shares listing to the OTC Markets. Meta Platforms (META) shares retreated nearly
Why Teradyne Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Shares of Teradyne, Inc. (NASDAQ:TER) rose sharply in today's pre-market trading after the company posted upbeat first-quarter results and issued strong second-quarter forecast.Teradyne posted adjuste
Biophytis Announces Transfer of ADSs to OTC Market
ADSs delisted from Nasdaq, which will result in meaningful savingsADSs transferred to OTC Pink market; Company will apply to trade on OTCQB marketBiophytis remains listed on Euronext Growth Paris as its primary trading
European Equities Traded in the US as American Depositary Receipts Jump in Tuesday Trading
European equities traded in the US as American depositary receipts jumped Tuesday morning, advancing 1.31% to 1,362.51 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led
Express News | Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Biophytis To Carry Out 1-for-40 Reverse Stock Split On April 23rd, 2024
April 20th - $Biophytis(BPTS.US)$ is about to implement a 1-for-40 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from April 23rd, 2024.$Biophytis(BPTS.US)$ sli
Express News | Biophytis Shares Are Trading Lower After the Company Announced That It Will Change the Ratio of Its American Depositary Shares From 100 to 4,000
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down
European equities traded in the US as American depositary receipts were trending higher Friday morning, rising 0.46% to 1,330.20 on the S&P Europe Select ADR Index. Despite the gain, the index remains
Biophytis BPTS ADS Ratio Change; Soligenix SNGX Offering
Biophytis Changes ADR Ratio From 100 to 4,000 Shares
Biophytis (BPTS) said Friday it is changing the ratio of its American depositary shares from a single unit representing 100 shares to 4,000 shares effective April 23. Shareholders holding ADRs of the
Biophytis Announces Ratio Change Under Its American Depositary Receipt ("ADR") Program
PARIS, FRANCE AND CAMBRIDGE, MA / ACCESSWIRE / April 19, 2024 / Biophytis SA , , a clinical-stage biotechnology company specialized in
Express News | Biophytis Shares Are Trading Higher. The Company Announced the Formation of a New Scientific Advisory Board to Support the Advancement of Its Phase 2 OBA Clinical Study in Obesity
Biophytis Announces New Scientific Advisory Board for Its Phase 2 OBA Clinical Study in Obesity
IND to be filed with the FDA in the coming weeksPARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / April 18, 2024 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"),
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading
European equities traded in the US as American depositary receipts were lower Tuesday morning, declining 0.67% to 1,332.69 on the S&P Europe Select ADR Index. From continental Europe, the gainers were
French Biotech Biophytis Files Patent Application for BIO101
Biophytis (ALBPS.PA) submitted a patent application to protect the intellectual property of its BIO101 lead drug candidate in combination with glucagon-like peptide-1 receptor agonists for obesity tre
No Data